Psoriasis
Immune-mediated disease treated to clear skin.
Psoriasis is a systemic immune-mediated disease that accelerates skin cell turnover, producing well-demarcated plaques with silvery scale. It commonly affects the elbows, knees, scalp and nails, and can involve the joints.
- None
- Downtime
- 4–8 wks
- First results
- Biologics
- Options
- 12 wks
- Review
- Vitamin D analogues & topicals
- Narrowband UVB phototherapy
- Systemic therapy
- Biological therapy
Diagnosed first, treated second.
It is also associated with metabolic and cardiovascular risk, which is why assessment goes beyond the skin. With phototherapy, systemic therapy and modern biologics, complete or near-complete clearance is now a standard expectation.
- 01Vitamin D analogues & topicals
- 02Narrowband UVB phototherapy
- 03Systemic therapy
- 04Biological therapy
- 05Comorbidity screening
- Thick scaly plaques
- Scalp or nail psoriasis
- Joint pain or stiffness with skin disease
- Disease unresponsive to topicals
- Significant impact on quality of life
How the treatment works
A sequence, not a single appointment — each step informs the next.
- 01
Assessment
Surface area, site severity and joint symptoms are scored at baseline.
- 02
Systemic review
Metabolic, cardiovascular and psoriatic arthritis screening is completed.
- 03
Treatment selection
Topicals, phototherapy, systemics or biologics chosen by severity and impact.
- 04
Monitoring
Response and laboratory safety are tracked at structured intervals.
Results measured, not promised.
What to expect
- 01Plaques cleared or near-cleared
- 02Scale and itch resolved
- 03Nail and scalp involvement improved
- 04Joint symptoms identified early
- 05Long remission periods
Begin with a diagnosis,
not a guess.
Share a few details and the clinic will reply with available consultation times for psoriasis — one-to-one with Dr. Arely.
- Response
- Within 24 hours
- Consultation
- One-to-one, 45 min
- Assessment
- Trichoscopy included
- Location
- Dr. Arely Clinic
Frequently asked
No, but long periods of completely clear skin are achievable with current therapy.
No. It is systemic, with joint, metabolic and cardiovascular associations that we screen for.
They have strong long-term safety data and are monitored with regular review and bloodwork.
Frequently. Stress, infection, injury and some medications are recognised triggers.